Bartlett, JG. Clostridium difficile infection: historic review. Anaerobe. 2009;15(6):227–229.Google Scholar

Kelly, CP, Pothoulakis, C, LaMont, JT. Clostridium difficile colitis. N Engl J Med. 1994;330(4):257–262.CrossRefGoogle ScholarPubMed

Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–1208.CrossRefGoogle ScholarPubMed

Kwon, JH, Olsen, MA, Dubberke, ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):123–134.CrossRefGoogle ScholarPubMed

Bartlett, JG. Narrative review: the new epidemic of Clostridium difficile–associated enteric disease. Ann Intern Med. 2006;145(10):758–764.CrossRefGoogle ScholarPubMed

Honda, H, Dubberke, ER. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol. 2014;30(1):54–62.Google Scholar

al Saif, N, Brazier, JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol. 1996;45(2):133–137.CrossRefGoogle ScholarPubMed

Bakri, MM, Brown, DJ, Butcher, JP, Sutherland, AD. Clostridium difficile in ready-to-eat salads, Scotland. Emerg Infect Dis. 2009;15(5):817–818.Google Scholar

Gould, LH, Limbago, B. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis. 2010;51(5):577–582.Google Scholar

Songer, JG, Trinh, HT, Killgore, GE, Thompson, AD, McDonald, LC, Limbago, BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15(5):819–21.CrossRefGoogle ScholarPubMed

Rupnik, M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin Microbiol Infect. 2007;13(5):457–459.CrossRefGoogle ScholarPubMed

Muto, CA, Blank, MK, Marsh, JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis. 2007;45(10):1266–1273.CrossRefGoogle Scholar

Lessa, FC, Mu, Y, Bamberg, WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834.Google Scholar

Dubberke, ER, Schaefer, E, Reske, KA, Zilberberg, M, Hollenbeak, CS, Olsen, MA. Attributable inpatient costs of recurrent Clostridium difficile infections. Infect Control Hosp Epidemiol. 2014;35(11):1400–1407.CrossRefGoogle ScholarPubMed

Chitnis, AS, Holzbauer, SM, Belflower, RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013;173(14):1359–1367.CrossRefGoogle ScholarPubMed

Alasmari, F, Seiler, SM, Hink, T, Burnham, CA, Dubberke, ER. Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis. 2014;59(2):216–222.CrossRefGoogle ScholarPubMed

Fekety, R, Kim, KH, Brown, D, Batts, DH, Cudmore, M, Silva, J, Jr. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am J Med. 1981;70(4):906–908.CrossRefGoogle ScholarPubMed

Jump, RL, Pultz, MJ, Donskey, CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother. 2007;51(8):2883–2887.Google Scholar

McFarland, LV, Mulligan, ME, Kwok, RY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204–210.CrossRefGoogle ScholarPubMed

Sunenshine, RH, McDonald, LC. Clostridium difficile–associated disease: new challenges from an established pathogen. Cleve Clin J Med. 2006;73(2):187–197.CrossRefGoogle ScholarPubMed

Hurley, BW, Nguyen, CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med. 2002;162(19):2177–2184.Google Scholar

Donskey, CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis. 2004;39(2):219–226.Google Scholar

Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–455.Google Scholar

Loo, VG, Bourgault, AM, Poirier, L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693–1703.CrossRefGoogle ScholarPubMed

Olsen, MA, Stwalley, D, Demont, C, Mahe, C, Dubberke, ER. Minimal contribution of age to risk of Clostridium difficile infection in the elderly. ID Week. 2015. 10-8-2015.Google Scholar

Bignardi, GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):1–15.Google Scholar

Dubberke, ER, Reske, KA, Seiler, S, Hink, T, Kwon, JH, Burnham, CA. Risk factors for acquisition and loss of C. difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;.Google Scholar

McFarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162(3):678–684.CrossRefGoogle Scholar

Zacharioudakis, IM, Zervou, FN, Pliakos, EE, Ziakas, PD, Mylonakis, E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381–390.Google Scholar

Bagdasarian, N, Rao, K, Malani, PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398–408.CrossRefGoogle ScholarPubMed

Wanahita, A, Goldsmith, EA, Musher, DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34(12):1585–1592.Google Scholar

Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):2887–2893.Google Scholar

Bartlett, JG, Gerding, DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S12–S18.Google Scholar

Stamper, PD, Alcabasa, R, Aird, D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47(2):373–378.Google Scholar

Wilkins, TD, Lyerly, DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol. 2003;41(2):531–534.Google Scholar

Dubberke, ER, Burnham, CD. Diagnosis of Clostridium difficile infection: treat the patient, not the test. JAMA Intern Med. 2015;1–2.Google Scholar

Aichinger, E, Schleck, CD, Harmsen, WS, Nyre, LM, Patel, R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):3795–3797.Google Scholar

Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J, Jr. Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459–477.Google Scholar

Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44(3):1145–1149.Google Scholar

Shanholtzer, CJ, Willard, KE, Holter, JJ, Olson, MM, Gerding, DN, Peterson, LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol. 1992;30(7):1837–1840.CrossRefGoogle Scholar

Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67–73.Google Scholar

van den Berg, RJ, Bruijnesteijn van Coppenraet, LS, Gerritsen, HJ, Endtz, HP, van der Vorm, ER, Kuijper, EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile–associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43(10):5338–5340.Google Scholar

Bartlett, JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334–339.Google Scholar

Shannon-Lowe, J, Matheson, NJ, Cooke, FJ, Aliyu, SH. Prevention and medical management of Clostridium difficile infection. BMJ. 2010;340:c1296.Google Scholar

Louie, TJ, Miller, MA, Mullane, KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–431.Google Scholar

Johnson, S, Louie, TJ, Gerding, DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345–354.Google Scholar

Johnson, S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58(6):403–410.Google Scholar

Garey, KW, Ghantoji, SS, Shah, DN, et al. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011;66(12):2850–2855.Google Scholar

Soriano, MM, Danziger, LH, Gerding, DN, Johnson, S. Novel fidaxomicin treatment regimens for patients with multiple clostridium difficile infection recurrences that are refractory to standard therapies. Open Forum Infect Dis. 2014;1(2):ofu069.Google Scholar

Cammarota, G, Ianiro, G, Gasbarrini, A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014 Jan 16.CrossRefGoogle ScholarPubMed

Hirsch, BE, Saraiya, N, Poeth, K, Schwartz, RM, Epstein, ME, Honig, G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 2015;15:191.Google Scholar

Orenstein, R, Dubberke, E, Hardi, R, et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD Study. Clin Infect Dis. 2015 Nov 12.Google Scholar

van Nood, E, Vrieze, A, Nieuwdorp, M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–415.CrossRefGoogle ScholarPubMed

Youngster, I, Russell, GH, Pindar, C, Ziv-Baran, T, Sauk, J, Hohmann, EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):1772–1778.Google Scholar

Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies, Food and Drug Administration, (2013).Google Scholar

Allen, SJ. The potential of probiotics to prevent Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):135–144.Google Scholar

Gerding, DN, Muto, CA, Owens, RC, Jr. Treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S32–S42.Google Scholar

Byrn, JC, Maun, DC, Gingold, DS, Baril, DT, Ozao, JJ, Divino, CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150–154.Google Scholar

Lamontagne, F, Labbe, AC, Haeck, O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267–272.Google Scholar

Pepin, J, Vo, TT, Boutros, M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52(3):400–405.Google Scholar

Sailhamer, EA, Carson, K, Chang, Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433–439.Google Scholar

Neal, MD, Alverdy, JC, Hall, DE, Simmons, RL, Zuckerbraun, BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423–427.Google Scholar

Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014;35(8):967–977.Google Scholar

Dubberke, ER, McMullen, KM, Mayfield, JL, et al. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol. 2009;30(4):332–337.Google Scholar

Dubberke, ER, Butler, AM, Hota, B, et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol. 2009;30(6):518–525.Google Scholar

Marschall, J, Mermel, LA, Fakih, M, et al. Strategies to prevent central line–associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753–771.Google Scholar

Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–2732.Google Scholar

Warren, DK, Zack, JE, Cox, MJ, Cohen, MM, Fraser, VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med. 2003;31(7):1959–1963.Google Scholar

Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014;35(6):628–645.Google Scholar

Weiss, K, Boisvert, A, Chagnon, M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol. 2009;30(2):156–162.Google Scholar

Gravel, D, Gardam, M, Taylor, G, et al. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada. Am J Infect Control. 2009;37(1):9–14.CrossRefGoogle ScholarPubMed

Wilkinson, K, Gravel, D, Taylor, G, et al. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control. 2011;39(3):177–182.CrossRefGoogle ScholarPubMed

Detsky, ME, Etchells, E. Single-patient rooms for safe patient-centered hospitals. JAMA. 2008;300(8):954–956.Google Scholar

Kundrapu, S, Jury, LA, Sitzlar, B, Sunkesula, VC, Sethi, AK, Donskey, CJ. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol. 2013;51(7):2365–2370.Google Scholar

Boyce, JM, Pittet, D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-16):1–45, quiz.Google Scholar

Landelle, C, Verachten, M, Legrand, P, Girou, E, Barbut, F, Buisson, CB. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(1):10–15.Google Scholar

Edmonds, SL, Zapka, C, Kasper, D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2013;34(3):302–305.Google Scholar

Shaughnessy, MK, Micielli, RL, Depestel, DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201–206.Google Scholar

Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect. 2009;71(1):49–56.Google Scholar

Kim, KH, Fekety, R, Batts, DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):42–50.Google Scholar

Dumford, DM III, Nerandzic, MM, Eckstein, BC, Donskey, CJ. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control. 2009;37(1):15–19.Google Scholar

Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100(1):32–40.Google Scholar

Cunningham, R, Dale, B, Undy, B, Gaunt, N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243–245.CrossRefGoogle ScholarPubMed

Merrigan, M, Venugopal, A, Mallozzi, M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192(19):4904–4911.Google Scholar

Dubberke, ER, Reske, KA, Noble-Wang, J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control. 2007;35(5):315–318.Google Scholar

Curry, SR, Muto, CA, Schlackman, JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57(8):1094–1102.Google Scholar

Eyre, DW, Griffiths, D, Vaughan, A, et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One. 2013;8(11):e78445.Google Scholar

Kaatz, GW, Gitlin, SD, Schaberg, DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol. 1988;127(6):1289–1294.Google Scholar

McMullen, KM, Zack, J, Coopersmith, CM, Kollef, M, Dubberke, E, Warren, DK. Use of hypochlorite solution to decrease rates of Clostridium difficile–associated diarrhea. Infect Control Hosp Epidemiol. 2007;28(2):205–207.CrossRefGoogle ScholarPubMed

Orenstein, R, Aronhalt, KC, McManus, JE Jr., Fedraw, LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011;32(11):1137–119.Google Scholar

Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31(4):995–1000.Google Scholar

Wilcox, MH, Fawley, WN, Wigglesworth, N, Parnell, P, Verity, P, Freeman, J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54(2):109–114.Google Scholar

Barbut, F, Menuet, D, Verachten, M, Girou, E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30(6):507–514.Google Scholar

Boyce, JM, Havill, NL, Otter, JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29(8):723–729.Google Scholar

Sitzlar, B, Deshpande, A, Fertelli, D, Kundrapu, S, Sethi, AK, Donskey, CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol. 2013;34(5):459–465.Google Scholar

Anderson, D, Chen, LF, Weber, DJ, et al. The benefits of enhanced terminal room (betr) disinfection study: a cluster randomized, multicenter crossover study with 2x2 factorial design to evaluate the impact of enhanced terminal room disinfection on acquisition and infection caused by multidrug-resistant organisms (MDRO). ID Week. 2015. 10-9-2015.Google Scholar

Boyce, JM, Havill, NL, Dumigan, DG, Golebiewski, M, Balogun, O, Rizvani, R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol. 2009;30(7):678–684.Google Scholar

Carling, PC, Parry, MF, Von Beheren, SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):1–7.CrossRefGoogle ScholarPubMed

Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.Google Scholar

Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194–200.Google Scholar

Levin, PD, Idrees, S, Sprung, CL, et al. Antimicrobial use in the ICU: indications and accuracy–an observational trial. J Hosp Med. 2012;7(9):672–678.Google Scholar

Camins, BC, King, MD, Wells, JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol. 2009;30(10):931–938.CrossRefGoogle Scholar

Owens, RC Jr., Donskey, CJ, Gaynes, RP, Loo, VG, Muto, CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008 ;46 Suppl 1:S19–S31.Google Scholar

Nuila, F, Cadle, RM, Logan, N, Musher, DM. Antibiotic stewardship and Clostridium difficile–associated disease. Infect Control Hosp Epidemiol. 2008;29(11):1096–1097.Google Scholar

Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112–S121.Google Scholar

Goldenberg, JZ, Ma, SS, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.Google Scholar

Pattani, R, Palda, VA, Hwang, SW, Shah, PS. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med. 2013;7(2):e56–e67.Google Scholar

Johnson, S, Maziade, PJ, McFarland, LV, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis. 2012;16(11):e786–e792.Google Scholar

Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ. Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):1543–1549.Google Scholar

Dubberke, ER, Butler, AM, Yokoe, DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010;31(10):1030–1037.Google Scholar

Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–2449.Google Scholar

Gao, XW, Mubasher, M, Fang, CY, Reifer, C, Miller, LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80 R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105(7):1636–1641.Google Scholar

Kotowska, M, Albrecht, P, Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21(5):583–590.Google Scholar

Hennequin, C, Kauffmann-Lacroix, C, Jobert, A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis. 2000;19(1):16–20.Google Scholar

Enache-Angoulvant, A, Hennequin, C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis. 2005;41(11):1559–1568.Google Scholar

Gouriet, F, Million, M, Henri, M, Fournier, PE, Raoult, D. Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis. 2012;31(9):2469–2480.Google Scholar

Eyre, DW, Cule, ML, Wilson, DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):1195–1205.Google Scholar

Lanzas, C, Dubberke, ER, Lu, Z, Reske, KA, Grohn, YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(6):553–561.Google Scholar

McDonald, EG, Milligan, J, Frenette, C, Lee, TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015;175(5):784–791.Google Scholar

Bignardi, GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):1–15.Google Scholar

Dubberke, ER, Reske, KA, Seiler, S, Hink, T, Kwon, JH, Burnham, CA. Risk factors for acquisition and loss of C. difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;.Google Scholar

McFarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162(3):678–684.CrossRefGoogle Scholar

Zacharioudakis, IM, Zervou, FN, Pliakos, EE, Ziakas, PD, Mylonakis, E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381–390.Google Scholar

Bagdasarian, N, Rao, K, Malani, PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398–408.CrossRefGoogle ScholarPubMed

Wanahita, A, Goldsmith, EA, Musher, DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34(12):1585–1592.Google Scholar

Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):2887–2893.Google Scholar

Bartlett, JG, Gerding, DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S12–S18.Google Scholar

Stamper, PD, Alcabasa, R, Aird, D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47(2):373–378.Google Scholar

Wilkins, TD, Lyerly, DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol. 2003;41(2):531–534.Google Scholar

Dubberke, ER, Burnham, CD. Diagnosis of Clostridium difficile infection: treat the patient, not the test. JAMA Intern Med. 2015;1–2.Google Scholar

Aichinger, E, Schleck, CD, Harmsen, WS, Nyre, LM, Patel, R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):3795–3797.Google Scholar

Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J, Jr. Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459–477.Google Scholar

Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44(3):1145–1149.Google Scholar

Shanholtzer, CJ, Willard, KE, Holter, JJ, Olson, MM, Gerding, DN, Peterson, LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol. 1992;30(7):1837–1840.CrossRefGoogle Scholar

Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67–73.Google Scholar

van den Berg, RJ, Bruijnesteijn van Coppenraet, LS, Gerritsen, HJ, Endtz, HP, van der Vorm, ER, Kuijper, EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile–associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43(10):5338–5340.Google Scholar

Bartlett, JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334–339.Google Scholar

Shannon-Lowe, J, Matheson, NJ, Cooke, FJ, Aliyu, SH. Prevention and medical management of Clostridium difficile infection. BMJ. 2010;340:c1296.Google Scholar

Louie, TJ, Miller, MA, Mullane, KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–431.Google Scholar

Johnson, S, Louie, TJ, Gerding, DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345–354.Google Scholar

Johnson, S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58(6):403–410.Google Scholar

Garey, KW, Ghantoji, SS, Shah, DN, et al. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011;66(12):2850–2855.Google Scholar

Soriano, MM, Danziger, LH, Gerding, DN, Johnson, S. Novel fidaxomicin treatment regimens for patients with multiple clostridium difficile infection recurrences that are refractory to standard therapies. Open Forum Infect Dis. 2014;1(2):ofu069.Google Scholar

Cammarota, G, Ianiro, G, Gasbarrini, A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014 Jan 16.CrossRefGoogle ScholarPubMed

Hirsch, BE, Saraiya, N, Poeth, K, Schwartz, RM, Epstein, ME, Honig, G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 2015;15:191.Google Scholar

Orenstein, R, Dubberke, E, Hardi, R, et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD Study. Clin Infect Dis. 2015 Nov 12.Google Scholar

van Nood, E, Vrieze, A, Nieuwdorp, M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–415.CrossRefGoogle ScholarPubMed

Youngster, I, Russell, GH, Pindar, C, Ziv-Baran, T, Sauk, J, Hohmann, EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):1772–1778.Google Scholar

Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies, Food and Drug Administration, (2013).Google Scholar

Allen, SJ. The potential of probiotics to prevent Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):135–144.Google Scholar

Gerding, DN, Muto, CA, Owens, RC, Jr. Treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S32–S42.Google Scholar

Byrn, JC, Maun, DC, Gingold, DS, Baril, DT, Ozao, JJ, Divino, CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150–154.Google Scholar

Lamontagne, F, Labbe, AC, Haeck, O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267–272.Google Scholar

Pepin, J, Vo, TT, Boutros, M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52(3):400–405.Google Scholar

Sailhamer, EA, Carson, K, Chang, Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433–439.Google Scholar

Neal, MD, Alverdy, JC, Hall, DE, Simmons, RL, Zuckerbraun, BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423–427.Google Scholar

Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014;35(8):967–977.Google Scholar

Dubberke, ER, McMullen, KM, Mayfield, JL, et al. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol. 2009;30(4):332–337.Google Scholar

Dubberke, ER, Butler, AM, Hota, B, et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol. 2009;30(6):518–525.Google Scholar

Marschall, J, Mermel, LA, Fakih, M, et al. Strategies to prevent central line–associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753–771.Google Scholar

Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–2732.Google Scholar

Warren, DK, Zack, JE, Cox, MJ, Cohen, MM, Fraser, VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med. 2003;31(7):1959–1963.Google Scholar

Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014;35(6):628–645.Google Scholar

Weiss, K, Boisvert, A, Chagnon, M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol. 2009;30(2):156–162.Google Scholar

Gravel, D, Gardam, M, Taylor, G, et al. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada. Am J Infect Control. 2009;37(1):9–14.CrossRefGoogle ScholarPubMed

Wilkinson, K, Gravel, D, Taylor, G, et al. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control. 2011;39(3):177–182.CrossRefGoogle ScholarPubMed

Detsky, ME, Etchells, E. Single-patient rooms for safe patient-centered hospitals. JAMA. 2008;300(8):954–956.Google Scholar

Kundrapu, S, Jury, LA, Sitzlar, B, Sunkesula, VC, Sethi, AK, Donskey, CJ. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol. 2013;51(7):2365–2370.Google Scholar

Boyce, JM, Pittet, D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-16):1–45, quiz.Google Scholar

Landelle, C, Verachten, M, Legrand, P, Girou, E, Barbut, F, Buisson, CB. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(1):10–15.Google Scholar

Edmonds, SL, Zapka, C, Kasper, D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2013;34(3):302–305.Google Scholar

Shaughnessy, MK, Micielli, RL, Depestel, DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201–206.Google Scholar

Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect. 2009;71(1):49–56.Google Scholar

Kim, KH, Fekety, R, Batts, DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):42–50.Google Scholar

Dumford, DM III, Nerandzic, MM, Eckstein, BC, Donskey, CJ. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control. 2009;37(1):15–19.Google Scholar

Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100(1):32–40.Google Scholar

Cunningham, R, Dale, B, Undy, B, Gaunt, N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243–245.CrossRefGoogle ScholarPubMed

Merrigan, M, Venugopal, A, Mallozzi, M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192(19):4904–4911.Google Scholar

Dubberke, ER, Reske, KA, Noble-Wang, J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control. 2007;35(5):315–318.Google Scholar

Curry, SR, Muto, CA, Schlackman, JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57(8):1094–1102.Google Scholar

Eyre, DW, Griffiths, D, Vaughan, A, et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One. 2013;8(11):e78445.Google Scholar

Kaatz, GW, Gitlin, SD, Schaberg, DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol. 1988;127(6):1289–1294.Google Scholar

McMullen, KM, Zack, J, Coopersmith, CM, Kollef, M, Dubberke, E, Warren, DK. Use of hypochlorite solution to decrease rates of Clostridium difficile–associated diarrhea. Infect Control Hosp Epidemiol. 2007;28(2):205–207.CrossRefGoogle ScholarPubMed

Orenstein, R, Aronhalt, KC, McManus, JE Jr., Fedraw, LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011;32(11):1137–119.Google Scholar

Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31(4):995–1000.Google Scholar

Wilcox, MH, Fawley, WN, Wigglesworth, N, Parnell, P, Verity, P, Freeman, J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54(2):109–114.Google Scholar

Barbut, F, Menuet, D, Verachten, M, Girou, E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30(6):507–514.Google Scholar

Boyce, JM, Havill, NL, Otter, JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29(8):723–729.Google Scholar

Sitzlar, B, Deshpande, A, Fertelli, D, Kundrapu, S, Sethi, AK, Donskey, CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol. 2013;34(5):459–465.Google Scholar

Anderson, D, Chen, LF, Weber, DJ, et al. The benefits of enhanced terminal room (betr) disinfection study: a cluster randomized, multicenter crossover study with 2x2 factorial design to evaluate the impact of enhanced terminal room disinfection on acquisition and infection caused by multidrug-resistant organisms (MDRO). ID Week. 2015. 10-9-2015.Google Scholar

Boyce, JM, Havill, NL, Dumigan, DG, Golebiewski, M, Balogun, O, Rizvani, R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol. 2009;30(7):678–684.Google Scholar

Carling, PC, Parry, MF, Von Beheren, SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):1–7.CrossRefGoogle ScholarPubMed

Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.Google Scholar

Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194–200.Google Scholar

Levin, PD, Idrees, S, Sprung, CL, et al. Antimicrobial use in the ICU: indications and accuracy–an observational trial. J Hosp Med. 2012;7(9):672–678.Google Scholar

Camins, BC, King, MD, Wells, JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol. 2009;30(10):931–938.CrossRefGoogle Scholar

Owens, RC Jr., Donskey, CJ, Gaynes, RP, Loo, VG, Muto, CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008 ;46 Suppl 1:S19–S31.Google Scholar

Nuila, F, Cadle, RM, Logan, N, Musher, DM. Antibiotic stewardship and Clostridium difficile–associated disease. Infect Control Hosp Epidemiol. 2008;29(11):1096–1097.Google Scholar

Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112–S121.Google Scholar

Goldenberg, JZ, Ma, SS, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.Google Scholar

Pattani, R, Palda, VA, Hwang, SW, Shah, PS. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med. 2013;7(2):e56–e67.Google Scholar

Johnson, S, Maziade, PJ, McFarland, LV, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis. 2012;16(11):e786–e792.Google Scholar

Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ. Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):1543–1549.Google Scholar

Dubberke, ER, Butler, AM, Yokoe, DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010;31(10):1030–1037.Google Scholar

Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–2449.Google Scholar

Gao, XW, Mubasher, M, Fang, CY, Reifer, C, Miller, LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80 R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105(7):1636–1641.Google Scholar

Kotowska, M, Albrecht, P, Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21(5):583–590.Google Scholar

Hennequin, C, Kauffmann-Lacroix, C, Jobert, A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis. 2000;19(1):16–20.Google Scholar

Enache-Angoulvant, A, Hennequin, C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis. 2005;41(11):1559–1568.Google Scholar

Gouriet, F, Million, M, Henri, M, Fournier, PE, Raoult, D. Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis. 2012;31(9):2469–2480.Google Scholar

Eyre, DW, Cule, ML, Wilson, DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):1195–1205.Google Scholar

Lanzas, C, Dubberke, ER, Lu, Z, Reske, KA, Grohn, YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(6):553–561.Google Scholar

McDonald, EG, Milligan, J, Frenette, C, Lee, TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015;175(5):784–791.Google Scholar

Bignardi, GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):1–15.Google Scholar

Dubberke, ER, Reske, KA, Seiler, S, Hink, T, Kwon, JH, Burnham, CA. Risk factors for acquisition and loss of C. difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;.Google Scholar

McFarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162(3):678–684.CrossRefGoogle Scholar

Zacharioudakis, IM, Zervou, FN, Pliakos, EE, Ziakas, PD, Mylonakis, E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381–390.Google Scholar

Bagdasarian, N, Rao, K, Malani, PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398–408.CrossRefGoogle ScholarPubMed

Wanahita, A, Goldsmith, EA, Musher, DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34(12):1585–1592.Google Scholar

Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):2887–2893.Google Scholar

Bartlett, JG, Gerding, DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S12–S18.Google Scholar

Stamper, PD, Alcabasa, R, Aird, D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47(2):373–378.Google Scholar

Wilkins, TD, Lyerly, DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol. 2003;41(2):531–534.Google Scholar

Dubberke, ER, Burnham, CD. Diagnosis of Clostridium difficile infection: treat the patient, not the test. JAMA Intern Med. 2015;1–2.Google Scholar

Aichinger, E, Schleck, CD, Harmsen, WS, Nyre, LM, Patel, R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):3795–3797.Google Scholar

Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J, Jr. Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459–477.Google Scholar

Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44(3):1145–1149.Google Scholar

Shanholtzer, CJ, Willard, KE, Holter, JJ, Olson, MM, Gerding, DN, Peterson, LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol. 1992;30(7):1837–1840.CrossRefGoogle Scholar

Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67–73.Google Scholar

van den Berg, RJ, Bruijnesteijn van Coppenraet, LS, Gerritsen, HJ, Endtz, HP, van der Vorm, ER, Kuijper, EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile–associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43(10):5338–5340.Google Scholar

Bartlett, JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334–339.Google Scholar

Shannon-Lowe, J, Matheson, NJ, Cooke, FJ, Aliyu, SH. Prevention and medical management of Clostridium difficile infection. BMJ. 2010;340:c1296.Google Scholar

Louie, TJ, Miller, MA, Mullane, KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–431.Google Scholar

Johnson, S, Louie, TJ, Gerding, DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345–354.Google Scholar

Johnson, S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58(6):403–410.Google Scholar

Garey, KW, Ghantoji, SS, Shah, DN, et al. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011;66(12):2850–2855.Google Scholar

Soriano, MM, Danziger, LH, Gerding, DN, Johnson, S. Novel fidaxomicin treatment regimens for patients with multiple clostridium difficile infection recurrences that are refractory to standard therapies. Open Forum Infect Dis. 2014;1(2):ofu069.Google Scholar

Cammarota, G, Ianiro, G, Gasbarrini, A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014 Jan 16.CrossRefGoogle ScholarPubMed

Hirsch, BE, Saraiya, N, Poeth, K, Schwartz, RM, Epstein, ME, Honig, G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 2015;15:191.Google Scholar

Orenstein, R, Dubberke, E, Hardi, R, et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD Study. Clin Infect Dis. 2015 Nov 12.Google Scholar

van Nood, E, Vrieze, A, Nieuwdorp, M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–415.CrossRefGoogle ScholarPubMed

Youngster, I, Russell, GH, Pindar, C, Ziv-Baran, T, Sauk, J, Hohmann, EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):1772–1778.Google Scholar

Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies, Food and Drug Administration, (2013).Google Scholar

Allen, SJ. The potential of probiotics to prevent Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):135–144.Google Scholar

Gerding, DN, Muto, CA, Owens, RC, Jr. Treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S32–S42.Google Scholar

Byrn, JC, Maun, DC, Gingold, DS, Baril, DT, Ozao, JJ, Divino, CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150–154.Google Scholar

Lamontagne, F, Labbe, AC, Haeck, O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267–272.Google Scholar

Pepin, J, Vo, TT, Boutros, M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52(3):400–405.Google Scholar

Sailhamer, EA, Carson, K, Chang, Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433–439.Google Scholar

Neal, MD, Alverdy, JC, Hall, DE, Simmons, RL, Zuckerbraun, BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423–427.Google Scholar

Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014;35(8):967–977.Google Scholar

Dubberke, ER, McMullen, KM, Mayfield, JL, et al. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol. 2009;30(4):332–337.Google Scholar

Dubberke, ER, Butler, AM, Hota, B, et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol. 2009;30(6):518–525.Google Scholar

Marschall, J, Mermel, LA, Fakih, M, et al. Strategies to prevent central line–associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753–771.Google Scholar

Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–2732.Google Scholar

Warren, DK, Zack, JE, Cox, MJ, Cohen, MM, Fraser, VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med. 2003;31(7):1959–1963.Google Scholar

Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014;35(6):628–645.Google Scholar

Weiss, K, Boisvert, A, Chagnon, M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol. 2009;30(2):156–162.Google Scholar

Gravel, D, Gardam, M, Taylor, G, et al. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada. Am J Infect Control. 2009;37(1):9–14.CrossRefGoogle ScholarPubMed

Wilkinson, K, Gravel, D, Taylor, G, et al. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control. 2011;39(3):177–182.CrossRefGoogle ScholarPubMed

Detsky, ME, Etchells, E. Single-patient rooms for safe patient-centered hospitals. JAMA. 2008;300(8):954–956.Google Scholar

Kundrapu, S, Jury, LA, Sitzlar, B, Sunkesula, VC, Sethi, AK, Donskey, CJ. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol. 2013;51(7):2365–2370.Google Scholar

Boyce, JM, Pittet, D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-16):1–45, quiz.Google Scholar

Landelle, C, Verachten, M, Legrand, P, Girou, E, Barbut, F, Buisson, CB. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(1):10–15.Google Scholar

Edmonds, SL, Zapka, C, Kasper, D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2013;34(3):302–305.Google Scholar

Shaughnessy, MK, Micielli, RL, Depestel, DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201–206.Google Scholar

Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect. 2009;71(1):49–56.Google Scholar

Kim, KH, Fekety, R, Batts, DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):42–50.Google Scholar

Dumford, DM III, Nerandzic, MM, Eckstein, BC, Donskey, CJ. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control. 2009;37(1):15–19.Google Scholar

Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100(1):32–40.Google Scholar

Cunningham, R, Dale, B, Undy, B, Gaunt, N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243–245.CrossRefGoogle ScholarPubMed

Merrigan, M, Venugopal, A, Mallozzi, M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192(19):4904–4911.Google Scholar

Dubberke, ER, Reske, KA, Noble-Wang, J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control. 2007;35(5):315–318.Google Scholar

Curry, SR, Muto, CA, Schlackman, JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57(8):1094–1102.Google Scholar

Eyre, DW, Griffiths, D, Vaughan, A, et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One. 2013;8(11):e78445.Google Scholar

Kaatz, GW, Gitlin, SD, Schaberg, DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol. 1988;127(6):1289–1294.Google Scholar

McMullen, KM, Zack, J, Coopersmith, CM, Kollef, M, Dubberke, E, Warren, DK. Use of hypochlorite solution to decrease rates of Clostridium difficile–associated diarrhea. Infect Control Hosp Epidemiol. 2007;28(2):205–207.CrossRefGoogle ScholarPubMed

Orenstein, R, Aronhalt, KC, McManus, JE Jr., Fedraw, LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011;32(11):1137–119.Google Scholar

Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31(4):995–1000.Google Scholar

Wilcox, MH, Fawley, WN, Wigglesworth, N, Parnell, P, Verity, P, Freeman, J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54(2):109–114.Google Scholar

Barbut, F, Menuet, D, Verachten, M, Girou, E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30(6):507–514.Google Scholar

Boyce, JM, Havill, NL, Otter, JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29(8):723–729.Google Scholar

Sitzlar, B, Deshpande, A, Fertelli, D, Kundrapu, S, Sethi, AK, Donskey, CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol. 2013;34(5):459–465.Google Scholar

Anderson, D, Chen, LF, Weber, DJ, et al. The benefits of enhanced terminal room (betr) disinfection study: a cluster randomized, multicenter crossover study with 2x2 factorial design to evaluate the impact of enhanced terminal room disinfection on acquisition and infection caused by multidrug-resistant organisms (MDRO). ID Week. 2015. 10-9-2015.Google Scholar

Boyce, JM, Havill, NL, Dumigan, DG, Golebiewski, M, Balogun, O, Rizvani, R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol. 2009;30(7):678–684.Google Scholar

Carling, PC, Parry, MF, Von Beheren, SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):1–7.CrossRefGoogle ScholarPubMed

Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.Google Scholar

Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194–200.Google Scholar

Levin, PD, Idrees, S, Sprung, CL, et al. Antimicrobial use in the ICU: indications and accuracy–an observational trial. J Hosp Med. 2012;7(9):672–678.Google Scholar

Camins, BC, King, MD, Wells, JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol. 2009;30(10):931–938.CrossRefGoogle Scholar

Owens, RC Jr., Donskey, CJ, Gaynes, RP, Loo, VG, Muto, CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008 ;46 Suppl 1:S19–S31.Google Scholar

Nuila, F, Cadle, RM, Logan, N, Musher, DM. Antibiotic stewardship and Clostridium difficile–associated disease. Infect Control Hosp Epidemiol. 2008;29(11):1096–1097.Google Scholar

Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112–S121.Google Scholar

Goldenberg, JZ, Ma, SS, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.Google Scholar

Pattani, R, Palda, VA, Hwang, SW, Shah, PS. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med. 2013;7(2):e56–e67.Google Scholar

Johnson, S, Maziade, PJ, McFarland, LV, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis. 2012;16(11):e786–e792.Google Scholar

Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ. Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):1543–1549.Google Scholar

Dubberke, ER, Butler, AM, Yokoe, DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010;31(10):1030–1037.Google Scholar

Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–2449.Google Scholar

Gao, XW, Mubasher, M, Fang, CY, Reifer, C, Miller, LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80 R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105(7):1636–1641.Google Scholar

Kotowska, M, Albrecht, P, Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21(5):583–590.Google Scholar

Hennequin, C, Kauffmann-Lacroix, C, Jobert, A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis. 2000;19(1):16–20.Google Scholar

Enache-Angoulvant, A, Hennequin, C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis. 2005;41(11):1559–1568.Google Scholar

Gouriet, F, Million, M, Henri, M, Fournier, PE, Raoult, D. Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis. 2012;31(9):2469–2480.Google Scholar

Eyre, DW, Cule, ML, Wilson, DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):1195–1205.Google Scholar

Lanzas, C, Dubberke, ER, Lu, Z, Reske, KA, Grohn, YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(6):553–561.Google Scholar

McDonald, EG, Milligan, J, Frenette, C, Lee, TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015;175(5):784–791.Google Scholar